Stay updated on Autologous Lymphocytes in CLL/SLL Clinical Trial
Sign up to get notified when there's something new on the Autologous Lymphocytes in CLL/SLL Clinical Trial page.

Latest updates to the Autologous Lymphocytes in CLL/SLL Clinical Trial page
- CheckyesterdayChange DetectedThe Locations section was updated to include the listed state sites (Florida, North Carolina, Ohio, Pennsylvania, Tennessee, Utah) under a new Locations header, replacing the previous location entries.SummaryDifference0.7%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedPage version updated from v3.2.0 to v3.3.2; no substantive changes to the study details, eligibility criteria, or endpoints are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the government funding lapse notice about NIH Clinical Center operations and related status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedMinor updates to Study Record dates and metadata were observed, while core study content and eligibility details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedMajor changes: version updated to v3.2.0 and a new government-operation status notice added; a specific resource (B-cell chronic lymphocytic leukemia) was removed.SummaryDifference4%

- Check87 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Autologous Lymphocytes in CLL/SLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous Lymphocytes in CLL/SLL Clinical Trial page.